HYPE Treasury Expansion Targets $1B Through SEC Filing

Hyperliquid Strategies has filed an S-1 registration statement with the Securities and Exchange Commission seeking to raise $1 billion through a public offering. The proceeds will fund additional HYPE token acquisitions and general corporate operations.

The Wednesday

reveals plans to offer 160 million shares of common stock. Chardan Capital Markets serves as the financial advisor for the offering.

Hyperliquid Strategies represents a pending merger between Nasdaq-listed biotech firm Sonnet BioTherapeutics and special purpose acquisition company Rorschach I LLC. The transaction aims to create a crypto treasury company focused on the Hyperliquid ecosystem and expects to close before year-end.

Former Barclays CEO Bob Diamond will chair the merged entity, with David Schamis serving as chief executive officer. The company will trade on Nasdaq under a new ticker yet to be announced.

The firm currently holds 12.6 million HYPE tokens and $305 million in cash. The additional capital will primarily support HYPE token accumulation to expand the treasury position.

The company plans to stake substantially all HYPE holdings to generate ongoing rewards. It may also explore other

activities within the Hyperliquid ecosystem following internal assessments.